NCT04978389 is a clinical trial in Ventricular Failure, sponsored by University Hospital, Montpellier.

Who is sponsoring NCT04978389?

NCT04978389 is sponsored by University Hospital, Montpellier.

What condition does NCT04978389 study?

NCT04978389 studies Ventricular Failure.

Is NCT04978389 still recruiting?

NCT04978389 is currently completed. Last updated 2 February 2022.

Last reviewed 2022-02-02 · How we verify

NCT04978389

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Inter-observer Reproductibility of Visual Estimation of Left Ventricular Ejection Fraction in Critical Care

Completed Last updated 2 February 2022

What this trial tests

trial in Ventricular Failure in 10 participants. Completed in 20 December 2021.

Timeline

1 September 2021

Primary endpoint
1 December 2021

20 December 2021

Quick facts

Lead sponsor	University Hospital, Montpellier
Status	Completed
Study type	OBSERVATIONAL
Enrollment	10
Start date	1 September 2021
Primary completion	1 December 2021
Estimated completion	20 December 2021
Sites	1 location across France

Conditions studied

Ventricular Failure — all drugs for Ventricular Failure →

Sponsor

University Hospital, Montpellier

Who can join

Adults 18 to 80, any sex, with Ventricular Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Inter-observer reproductibility of visual estimation of left ventricular ejection fraction is known to be good in cardiology but has not been studied in ICU. The goal of the study is to determine if this reproductibility is good enough.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Montpellier trials

Trials by the same sponsor.

NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04978389 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
Last refreshed: 2 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04978389.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing